FDA Approves Another Opioid Antagonist Nasal Spray – UPDATED
Opvee is approved by the federal agency to combat opioid overdoses.
Opvee is approved by the federal agency to combat opioid overdoses.
Both Type 2 diabetics and those who are concerned with weight loss are worried about scarcity of Ozempic.
Xylazine is making its way into the illicit drug supply in the U.S., causing devastating effects.
Disrupted sleep can cause significant cardiovascular symptoms.
First-of-its-kind sickle cell pain management app provides a safe, interactive, and convenient way for patients to learn about, track, assess, and communicate with their doctors about sickle cell pain.
Fentanyl and other potent opioids are mainly to blame for increase in overdose fatalities.
Remote urine screenings are effective but could be subject to tampering.
Global longitudinal strain can accurately predict adverse outcomes in patients with HF and diabetes.
Delaware Behavioral Health Consortium awards funds for fighting the opioid epidemic.
Student and engineer creates a highly portable pocket inhaler for asthmatics.